|
1
|
Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins.
|
Proc Natl Acad Sci U S A
|
1992
|
3.25
|
|
2
|
A potential transcriptional activation element in the p53 protein.
|
Oncogene
|
1990
|
2.07
|
|
3
|
Intracellular leucine zipper interactions suggest c-Myc hetero-oligomerization.
|
Mol Cell Biol
|
1991
|
1.84
|
|
4
|
Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.
|
Mol Cell Biol
|
1992
|
1.39
|
|
5
|
E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein.
|
Nucleic Acids Res
|
1996
|
1.21
|
|
6
|
Mechanisms of hemolysis-associated platelet activation.
|
J Thromb Haemost
|
2013
|
1.17
|
|
7
|
Near-infrared spectra absorbance of blood from sickle cell patients and normal individuals.
|
Hematology
|
2009
|
0.83
|
|
8
|
The mUBC9 murine ubiquitin conjugating enzyme interacts with the E2A transcription factors.
|
Gene
|
1997
|
0.81
|
|
9
|
Successful treatment of life-threatening acute chest syndrome of sickle cell disease with venovenous extracorporeal membrane oxygenation.
|
J Pediatr Hematol Oncol
|
1997
|
0.78
|
|
10
|
DNA binding by the Myc oncoproteins.
|
Cancer Treat Res
|
1992
|
0.76
|
|
11
|
Homozygous factor-V mutation as a genetic cause of perinatal thrombosis and cerebral palsy.
|
Dev Med Child Neurol
|
1999
|
0.75
|
|
12
|
Steroid receptors, transcription factors, and gene expression. AACR special conference in cancer research.
|
Cancer Res
|
1990
|
0.75
|
|
13
|
Childhood Hodgkin and non-Hodgkin lymphomas.
|
Pediatr Rev
|
1990
|
0.75
|
|
14
|
Low-dose methotrexate therapy for hepatoblastoma.
|
Cancer Chemother Pharmacol
|
1991
|
0.75
|